Browse Results

  • Division: : Cancer Center


There are 196 clinical trial(s) matching your criteria.

Back

A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions for the Treatment of Keratoconjuctivitis Sicca in Patients with Chronic Ocular Graft versus Host Disease

Investigator: Victor Perez quinones

Institutional Protocol #: 20140195

National Clinical Trials Identifier: NCT02040623

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase: Phase II

Enrolling Since: 1/16/2015

A Phase 2B, Randomized, Controlled, Multicenter, Open-Label Study of the Efficacy and Immune Response of GVAX Pancreas Vaccine (with Cyclophosphamide) and CRS-207 Compared to Chemotherapy or to CRS-207 Alone in Adults with Previously-Treated Metastatic Pancreatic Adenocarcinoma

Investigator: Nicolas Acquavella

Institutional Protocol #: 20140013

National Clinical Trials Identifier: NCT02004262

Division: Cancer Center

Therapeutic Area: Pancreatic, Liver, and Related Cancers

Phase: Phase II

Enrolling Since: 10/9/2014

Transplant Registry Reporting

Investigator: Martin Andreansky

Institutional Protocol #: 20057012

National Clinical Trials Identifier: N/A

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase: N/A

Enrolling Since: 8/20/2012

Thyroid cancer and MMPs

Investigator: Sharon Elliot

Institutional Protocol #: 20057541

National Clinical Trials Identifier: N/A

Division: Cancer Center

Therapeutic Area: Thyroid and Other Endocrine Cancers

Phase: N/A

Enrolling Since: 6/24/2008

Back